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Edited by Hans EklundAbstract Coenzyme A (CoA) biosynthesis is initiated by panto-
thenate kinase (PanK) and CoA levels are controlled through dif-
ferential expression and feedback regulation of PanK isoforms.
PanK2 is a mitochondrial protein in humans, but comparative
genomics revealed that acquisition of a mitochondrial targeting
signal was limited to primates. Human and mouse PanK2 pos-
sessed similar biochemical properties, with inhibition by acetyl-
CoA and activation by palmitoylcarnitine. Mouse PanK2 local-
ized in the cytosol, and the expression of PanK2 was higher in
human brain compared to mouse brain. Diﬀerences in expression
and subcellular localization should be considered in developing a
mouse model for human PanK2 deﬁciency.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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CoA1 is an essential cofactor that plays a central metabolic
role as the predominant acyl group carrier in living organisms
[1]. Regulation of the cofactor concentration is achieved
through feedback inhibition of pantothenate kinase (PanK),
the ﬁrst enzyme in the biosynthetic pathway [2–4] catalyzing
the ATP-dependent phosphorylation of pantothenate. Mam-
mals express four catalytically active isoforms that have diﬀer-
ent sensitivities to inhibition by free CoA or CoA thioesters
[5–7]. PanKs share a >80% identical catalytic core [5,6,8]
attached to unrelated N-terminal extensions that range from
a few residues in the case of PanK1b and PanK3 to 100–
200 residues in the case of PanK1a and PanK2. The N-termi-
nus of human PanK2 (hPanK2) directs it to the mitochondria
where hPanK2 is sequentially processed twice to yield a
48 kDa mature protein [8–10]. A catalytically active hPanK2
inside the mitochondria was irreconcilable with the high orga-
nelle CoA concentration [11,12] until the discovery of palmi-
toylcarnitine as a positive regulator of hPanK2 [13].
Palmitoylcarnitine releases the acetyl-CoA inhibition by com-*Corresponding author. Fax: +1 901 495 3099.
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doi:10.1016/j.febslet.2007.08.056peting for its binding site, and this regulatory mechanism acti-
vates hPanK2 when the mitochondrial demand for CoA is
high for b-oxidation.
Pantothenate kinase-associated neurodegeneration (PKAN)
is a rare autosomal recessive disease caused by mutations in
the PANK2 gene [14,15]. PKAN patients exhibit pathological
accumulation of iron in the brain, movement and speech de-
fects [14–16]. This disease suggests an important role for mito-
chondrial PanK2 in mammalian physiology; however, the
Pank2 knockout mice do not recapitulate the neurological
abnormalities found in humans [17]. This study shows that
although the biochemical regulatory properties of the two en-
zymes are indistinguishable, there are signiﬁcant diﬀerences in
gene structure, subcellular localization of the proteins and rel-
ative abundance of PanK2 expression in human and murine
tissues.2. Materials and methods
2.1. Cloning of the murine Pank2 and generation of cell lines
A 1.6 kb fragment encoding the long form of mPanK2 [8] was
assembled from 3 ESTs (NCBI accession numbers BG091057,
CB247865 and BQ715345) and ligated into pcDNA3.1+ between Eco-
RI and XbaI restriction sites to generate pPJ256. For biochemical as-
says, HEK293T cells (gift from Suzanne Baker, St. Jude Children’s
Research Hospital) were transiently transfected for 48 h with either
pPJ256 or pKM56 (a pcDNA3.1-derived vector encoding the mature
hPanK2 (residues 141–570) [7]). For immunoﬂuorescence analysis,
HEK293 cells (ATCC) were stably transfected with either pPJ256 or
pKM4 (a pcDNA3.1-derived vector encoding the mitochondrial pre-
cursor hPanK2 (residues 1–570) [7]). Clones were selected in growth
medium containing 600 lg/ml of G418 and screened for expression.
2.2. Real time qRT-PCR analysis
Total RNA was either purchased (mouse and human brain sections,
human liver, brain and testes) or isolated from whole brain and cau-
date nucleus region, whole liver and testes of 2–3 mice, using the TRI-
ZOL reagent. Synthesis of ﬁrst-strand cDNA was obtained by reverse
transcription using SuperScript II RNase H reverse transcriptase,
the RNA templates and random primers. Quantitative real-time
PCR was performed in triplicate using the ABI Prism 7700 Sequence
Detection System with the primers and probes listed in Table S1. The
Taqman human and rodent GAPDH (Applied Biosystems) were used
as controls. All of the values were compared using the CT method [18],
and the amount of cDNA (2DCT) was reported relative to glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) mRNA.
2.3. Western blot, immunoﬂuorescence and mitochondria isolation
Peptides corresponding to protein stretches unique to mPanK2
(GESADSEARRRDPLRRR) and hPanK2 (EGRRQEPLRRRAS-
SASV) were synthesized and coupled to keyhole limpet hemocyanin
and polyclonal antisera raised in rabbits. Aﬃnity puriﬁcation wasblished by Elsevier B.V. All rights reserved.
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jugated protein A was used as the secondary antibody at a dilution of
1:5000 to detect proteins in the western blots. The membranes were
then stripped using a recycling kit (Alpha Diagnostic International)
and reprobed with antibodies against the mitochondrial marker pyru-
vate dehydrogenase or the cytosolic marker b-actin used at concentra-
tions of 2.5 lg/ml and 5 lg/ml, respectively. The immuno complexes
were detected using the ECL kit (GE Healthcare).
The localization of mPanK2 and hPanK2 was determined by
confocal microscopy using a Zeiss LSM 510 META multiphoton
microscope with a Plan-Neoﬂuor 100·/1.3 oil immersion objective.
HEK293 cell lines grown in chamber slides were incubated with
250 nM MitoTracker red CMXRos to stain the mitochondria. Cells
were then ﬁxed with 3.7% formaldehyde, permeabilized with 0.2% Tri-
ton X-100, and incubated with the mPanK2 and hPanK2 antibodies.
Anti-rabbit IgG conjugated to Alexa Fluor 488 was used to visualize
the proteins. The slides were mounted with ProLong Gold antifade
reagent plus DAPI.
Heavy mitochondria were isolated from wild type and Pank2 knock-
out mouse brain as described by Graham [20].
2.4. Pantothenate kinase assay
The lysates of transfected HEK293T cells were obtained for measur-
ing the pantothenate kinase activity as described previously [7]. Brieﬂy,
the reaction mixtures contained 45 lM D-[1-14C]pantothenate (speciﬁc
activity 27.5 mCi/mmol), 250 lM ATP pH 7.0, 10 mM MgCl2, 0.1 M
Tris–HCl pH 7.5, 5 lg of protein and varying concentrations of acet-
yl-CoA or palmitoylcarnitine.
2.5. Bioinformatic analysis
Genomic sequences for human (chromosome 20, NT_011387.8),
chimpanzee (chromosome 20, NW_001230484), cow (chromosome
13, NW_001493148.1), dog (chromosome 24 NW_876277.1), cat (no
chromosome information, AANGO1231943.1) and mouse Pank2
(chromosome 2, NW_000178.1) were retrieved from NCBI. The maca-
que genomic sequence was retrieved from the sequencing center’s web-
site (http://www.hgsc.bcm.tmc.edu/projects/rmacaque/). Sequence
comparisons were performed using the VISTA tools for comparative
genomics (http://genome.lbl.gov/vista/index.shtml) [21].Fig. 1. DNA level sequence similarity of the 5 0-untranslated regions and exo
using the VISTA set of tools for comparative genomics with human PANK
predicted start codons in the corresponding organisms. The region correspon
and the positions of the mitochondrial processing peptidase cleavage sites [12.6. Materials
Materials were purchased from the following suppliers: oligonucleo-
tides and probes from the Hartwell Center at the St. Jude Children’s
Research Hospital; Poly(A)+ RNAs from mouse and human brain sec-
tions, human liver, brain and testes from Clontech; molecular biology
reagents from Qiagen; restriction enzymes and T4 DNA ligase from
Promega; SuperScript II RNase H reverse transcriptase, TRIZOL
reagent, and pcDNA3.1 vectors from Invitrogen; Real-time PCR
mix from Applied Biosystems; Bradford dye-binding protein assay
solution from Bio-Rad; D-[1-14C]pantothenate (speciﬁc activity,
55 mCi/mmol) from American Radiolabeled Chemicals. PanK2 knock-
out mice were kindly provided by Gitschier [17]. All other reagents
were of analytical grade or better and were obtained from Sigma
Chemical Co.3. Results and discussion
The amino-terminus of hPanK2 contains a mitochondrial
targeting sequence (residues 1–140) that is encoded by exon 1
[8]. The nucleotide sequences from six organisms were com-
pared using the VISTA tools for comparative genomics
(Fig. 1). This analysis revealed that while the macaque se-
quence encoded an intact mitochondrial targeting sequence,
the aligned nucleotide regions from mouse, cat, dog and cow
were not predicted to be translated. The predicted ATG start
codon in these organisms corresponded to residue 123 of
hPanK2 and excluded the mitochondrial targeting sequence.
The targeting sequence was found in the predicted chimpanzee
PanK2 protein (NCBI accession number XP_001163366) but
the encoding gene was not included in the VISTA analysis
due to the poor quality of the downstream DNA data. These
data indicated that emergence of a mitochondrial targeting
sequence occurred following the divergence of primates andn 1 of six mammalian PanKs. Genomic DNA sequences were aligned
2 as the reference sequence. Black arrows indicate the positions of the
ding to the human mitochondrial targeting signal has been shadowed
0] are indicated by the scissor symbol at the top.
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ent properties than the human isoform.
We compared the mature hPanK2 to full length mPanK2 to
determine if there were diﬀerences in their regulatory proper-
ties. The two enzymes were similarly inhibited by acetyl-CoA
and de-inhibited by palmitoylcarnitine (Fig. 2). The acetyl-
CoA IC50s were estimated at 125 nM for hPanK2 and
62.5 nM for mPanK2 (Fig. 2A), and the concentration of
pamitoylcarnitine that maximally restored the activity was
16 lM in both cases (Fig. 2B). Thus, the regulation of PanK2
in both species was similar. The diﬀerence in the acetyl-CoA
IC50 values between mPanK2 and hPanK2 (0.06 lM vs.
0.12 lM) is not considered to be signiﬁcant in comparison with
the IC50 values determined for the other PanK isoforms which
are 10-fold and 100-fold higher, e.g., PanK3, 1 lM; PanK1b,
10 lM [6].
Next, the mRNA expression levels of the murine and human
PanK isoforms in brain, testes and liver were quantiﬁedFig. 2. Regulatory properties of mPank2 and hPank2. (A) Acetyl-CoA
inhibited both mPanK2 (d) and the mature form of hPanK2 [7] (s)
with similar IC50s of 62.5 and 125 nM, respectively. (B) Inhibition by
acetyl-CoA was released by the addition of palmitoylcarnitine. The
enzymes were incubated with ﬁxed concentrations of acetyl-CoA
corresponding to the respective IC50s and with increasing amounts of
the activator. The data represent the average of two independent
experiments ± the standard error.(Fig. 3). Expression of PanK4 was not taken into account
because it does not exhibit PanK activity [22]. PANK1 tran-
scripts (PANK1a + PANK1b) dominated human liver,
whereas Pank1 transcripts (Pank1a + Pank1b) in mouse liver
were equivalent to Pank3 transcripts (Fig. 3) and lower than
in human, relative to the expression of glyceraldehyde-3-phos-
phate dehydrogenase mRNA, a metabolic housekeeping gene
which was quantiﬁed as a measure of the total mRNA pool.
PANK2 transcripts, on the other hand, were relatively higher
than PANK1 and equivalent to PANK3 in human brain,
whereas Pank2 transcripts were low in mouse brain and Pank3
expression was highest. Pank2 transcripts were extremely high
in mouse testis accounting for 46% of the expressed isoforms,
but were considerably less abundant in human testis. Human
PANK2 transcripts were highest in brain, and represented
45% of the PANK transcripts. A detailed analysis of speciﬁc
areas of the brain revealed a high expression of human PANK2
transcripts in the cerebellum, which controls motor coordina-
tion and movement, and, as previously reported, in the cau-
date nucleus [8] (Fig. 3D). The overall abundance of the
murine Pank transcripts was lower than what was measured
in the corresponding human brain fractions (Fig. 3C), but
the level of Pank2 was higher in the cerebellum and cerebral
cortex compared to whole brain. These data revealed signiﬁ-
cant diﬀerences in the tissue-speciﬁc distribution of PanK iso-
forms in mice and humans.
The localization of hPanK2 and mPanK2 was investigated
in situ by confocal immunoﬂuorescence microscopy using
mPanK2- and hPanK2-speciﬁc antibodies (Fig. 4). Unlike
the mitochondrial hPanK2, mPanK2 was found in the cytosol.
These results were the same in either the human cell line,
HEK293 (Fig. 4), or the mouse cell line, NIH3T3 (data not
shown). The cytosolic location of mPanK2 was conﬁrmed by
Western blotting analysis of cytosolic and mitochondrial frac-
tions obtained from the brains of wild-type and PanK2 knock-
out mice (Fig. 5). mPanK2 was found exclusively in wild type
cytosol and not in mitochondria. The size of the endogenous
PanK2 protein matched the size of mPanK2 predicted from
genomic analysis (48.6 kDa) indicating that mPanK2 was not
processed. The faint band appearing in the knockout cytosolic
fraction most likely represents non-speciﬁc binding of the anti-
body to an unrelated protein. It is larger than the recombinant
mPanK2 protein shown in the far right lane and can be seen
faintly in the WT cytosol as well.4. Conclusions
The comparison of the mouse and human PanK2 proteins
reveal signiﬁcant diﬀerences in their expression pattern and
subcellular localization. Perhaps the symptoms of PKAN dis-
ease in humans arise in part from an overall lack of suﬃcient
PanK activity in the brain. The fact that PanK2 comprises a
higher percentage of the total PanK enzyme in human brain
compared to mouse brain may contribute to the inability to
demonstrate a neurological phenotype in Pank2 knockout
mice [17]. However, PanK2 transcripts are high in the testis,
the organ system primarily aﬀected in the PanK2 knockout
mice [17]. The most surprising result is the ﬁnding that the
evolution of a mitochondrial targeting sequence occurred fol-
lowing the divergence of the primate lineage. Our data are
Fig. 3. PanK isozyme expression in murine and human tissues. (A, B) The abundance of murine (A) or human (B) PanK isoform mRNAs in brain,
testes and liver. (C, D) The same analysis was conducted on mRNA from speciﬁc regions of the murine (C) and human (D) brain. Individual samples
were analyzed in triplicate, averaged and plotted relative to mouse or human glyceraldehyde-3-phosphate dehydrogenase mRNA. All data are
plotted as means ± the standard error, and statistical signiﬁcance was assessed by the Students t-test: *, 0.01 < P < 0.05; **, 0.001 < P < 0.01; ***,
P < 0.0001; NS, not signiﬁcant. Analysis of variance by the ANOVA test between mouse and human PanK isoforms in each brain region (panels C
and D) resulted in signiﬁcance values of P 6 0.0001 for the diﬀerence in expression levels between the two species.
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mouse and human PanK2 proteins are associated with mito-
chondria which was based on the immunolocalization of the
proteins in transiently transfected COS7 cells and tissue sec-
tions. However, our examination of the same data suggests
that there is a diﬀerence between the localization of the
two proteins [9,17]. The biochemical regulatory properties
are essentially the same between the two proteins, indicating
that they perform the same function of monitoring the status
of mitochondrial b-oxidation via palmitoylcarnitine and that
mitochondrial localization is not required. However, the
location of hPanK2 in the mitochondria places the protein
in the same cellular compartment where palmitoylcarnitine
is generated, thus providing greater sensitivity to changesin the concentration of the ligand. The lower contribution
of PanK2 to the total PanK activity in mouse brain com-
pared to humans and its localization in the cytosol rather
than the mitochondria are two factors that need to be con-
sidered in the understanding of the role of PanK isoforms
in CoA homeostasis and in the development of a mouse
model that recapitulates the molecular aspects of human
PKAN disease. A recent report [23] suggests that pantothe-
nate-deﬁciency in wild-type mice leads to a movement disor-
der that may provide a phenocopy for human PKAN
disease, whereas pantothenate-deﬁciency in Pank2 knockout
mice causes precipitous death, similar to the global mouse
knockout of all pantothenate kinase isoforms with a chemi-
cal inhibitor [22].
Fig. 4. Subcellular localization of mPanK2 and hPanK2. (A–C) Stably transfected HEK293 cells expressing mPanK2, (E–G) the mitochondrial
precursor form of hPanK2 [7] or containing (D and H) the empty vector were cultured and prepared for immunoﬂuorescence as described under
‘Materials and Methods’. (B and F) Cells were incubated with MitoTracker red CMXRos and with speciﬁc antibodies against (A) mPanK2 or (E)
hPanK2, followed by incubation with anti-rabbit IgG conjugated to Alexa Fluor 488 green; nuclei were stained with DAPI (blue). Panels C and D
show the merged images for mPanK2 and empty vector, respectively; panels G and H show the merged images for hPanK2 and empty vector,
respectively. hPanK2 localized to the mitochondria, while mPanK2 was in the cytosol.
Fig. 5. Cytosolic localization of mPanK2 in mouse brain. The western
blot was performed using 200 lg of brain mitochondrial and cytosolic
fraction protein from wild-type and Pank2 knockout mice and the
speciﬁc mPanK2 antibody. 195 lg of cytosolic protein from knockout
mice were mixed with 5 lg of lysate protein from stably transfected
HEK293 cells expressing mPanK2 and used as a control. The blot was
then stripped and reprobed with anti-b-actin as a marker protein for
cytosol, and then with anti-pyruvate dehydrogenase (PDH), a mito-
chondrial marker protein.
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